CHD Price Prediction Next Week
Technical Analysis: Church & Dwight (CHD) shows mixed technical signals in the short term. The stock is currently trading at $105.34, slightly below its 20-day SMA of $105.92 and 60-day SMA of $106.22. RSI-14 at 49.26 indicates neutral momentum, while MACD shows a bearish divergence with -0.27.
Price Target Analysis: Recent analyst ratings present a cautious outlook:
- J.P. Morgan maintains Sell rating with $106 target
- Barclays maintains Sell with $93 target
- Consensus price target of $112.07 implies 6.4% upside
Fibonacci Levels for Next Week:
- Resistance levels: R1: $107.19, R2: $108.34, R3: $110.20
- Support levels: S1: $103.48, S2: $102.33, S3: $100.48
- Pivot point: $105.34
News Sentiment Impact: Recent insider activity shows mixed signals - while there has been increased selling overall, EVP Michael Read made a purchase of 1,900 shares in December 2024. The company's Q1 2025 guidance disappointed investors with projected revenue of $1.52 billion, below analyst expectations.
Price Prediction for Next Week: Based on technical indicators and recent price action:
- Likely trading range: $103.48 - $107.19
- Most probable scenario: Bearish trend continuation
- Target price: $103.50
Trading Recommendation: SELL
- Entry point: Current price ($105.34)
- Initial target: $103.50
- Stop loss: $107.20
Rationale:
- Bearish MACD crossover
- Price trading below key moving averages
- Weak Q1 guidance
- Multiple analyst sell ratings
- Increased insider selling activity
CHD Similar Chart Price Prediction
The price of CHD is predicted to go up 0.08%, based on the high correlation periods with BAX. The similarity of these two price pattern on the periods is 90.17%.
CHD
BAX
Up: 0.08%Similarity: 90.17%
CHD Revenue Forecast
CHD EPS Forecast
CHD FAQs
What is bull’s view on CHD?
What is bear's view on CHD?
What is CHD revenue forecast for next quarter？
What is CHD eps forecast for next quarter？
CHD VS S&P500
We think Church could boost sales by expanding the distribution of its recently acquired brands, TheraBreath mouthwash and Hero pimple patches, at home and abroad.
Church & Dwight's mix of value (40%) and premium (60%) products could afford some protection against an unfavorable economic backdrop.
The exit from the production of lower-margin private-label products (particularly vitamins) is unlocking an opportunity for margin expansion as the firm produces more of its own branded products where demand persists.
CHD Analyst's Forecast
Mark Astrachan
Stifel
Hold
2025-01-17
Price Target
$105 → $103
Downside
-3.26%
Stifel lowered the firm's price target on Church & Dwight to $103 from $105 and keeps a Hold rating on the shares. The firm updated estimates ahead of December quarter reporting, mainly reflecting recent negative foreign exchange movement, the analyst tells investors.
Lauren Lieberman
Barclays
Sell
2025-01-17
Price Target
$85 → $90
Downside
-15.47%
Andrea Teixeira
JP Morgan
Sell
2025-01-16
Price Target
$99 → $107
Upside
+0.7%
